
Bioextrax Investor Relations Material
Latest events

Q2 2025
Bioextrax

Q2 2025
27 Aug, 2025

Q1 2025
20 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Bioextrax
Access all reports
Bioextrax AB develops and commercializes a bio-extraction platform technology delivering high purity active ingredients from non-traditional sources with lower cost than traditional extraction methods like CO2. Bioextrax has developed specific patented and protected technology platforms to produce active pharmaceutical ingredients (APIs) such as Omega 3, polyunsaturated fatty acids, astaxanthin and squalene. Bioextrax AB is haedquartered in Lund, Sweden.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
BIOEX
Country
🇸🇪 Sweden